Mr Mrs Miss Ms Dr Other

Mr
Christian
Himmler

Patent Director

Munich Office Salzburg Office

Technology & Engineering

Telephone. +49(0) 891 259 9600
Email. chimmler@hgf.com

Experience

Christian has considerable experience in drafting and prosecuting patent applications in the fields of mechanical engineering, medical engineering and renewable energies. Practice areas include fuel cells, medical devices, utility engineering, automotive and aerospace technologies. Furthermore he deals with opposition and appeal procedures.

Christian is a fully qualified European Patent Attorney (EPA), with experience in the in the field of industrial property rights since 2006. In that time, Christian has been involved in all aspects of patent law practice, including the preparation (drafting) and prosecution of German, European, International (PCT) and overseas patent applications, as well as post-grant issues such as opposition and appeal proceedings and develops patent strategies for clients. Christian also handles non-European patent prosecution especially in USA, China, Japan, Australia and Canada.

His experience covers a variety of subject-matter in preparing patent applications and the corresponding granting process in the fields of mechanical engineering, aeronautical engineering, automotive engineering, utility engineering, medical engineering and renewable energies.

Christian earned his mechanical engineering degree at the Munich University of Applied Sciences. During his studies, he completed a first internship at a company involved in the aerospace industry, where he dealt with engines and valves for rockets. A second internship in the field of regenerative energies involved the development of fuel cells. He gained further experience as part of an internship in the automotive industry, and as a student trainee at a company that certified automotive components and at a company that was active in the field of fuel cell development.

Qualifications

Patent Attorney

Europe


DIPL.-ING

(FH)

OTHER

Dipl. -Ing (FH) Maschinenbau

Publications

12 HGF Attorneys Recognised as Managing IP Rising Stars 2025

View publication online

Managing IP Rising Stars 2024

View publication online

HGF is ranked in The Legal 500 Germany 2023 rankings

View publication online

From March 1 Patronus IP have merged with HGF

View publication online

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.